Social science and price transparency in direct-to-consumer prescription drug advertisements

Volume: 16, Issue: 6, Pages: 733 - 735
Published: Jun 1, 2020
Abstract
Policies that mandate list price disclosure in direct-to-consumer pharmaceutical advertising (DTCPA) cite price transparency among the benefits. The expectation is that price transparency will lead to changes in consumer behavior that will ultimately lower healthcare costs.The objective of this study was to assess the impact of price transparency on perceived level of information and consumer behaviors, specifically intentions to seek treatment...
Paper Details
Title
Social science and price transparency in direct-to-consumer prescription drug advertisements
Published Date
Jun 1, 2020
Volume
16
Issue
6
Pages
733 - 735
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.